Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2
Introduction 10
2.1 What Is This Report About? 10
3 Executive Summary
11
4 Definitions of Markets Covered in the Report 12
4.1 Diabetic Care
Devices 12
4.2 Glucose Monitoring Devices 12
4.2.1 Blood Glucose
Meters 12
4.2.2 Blood Glucose Strips 12
4.3 Insulin Delivery 12
4.3.1 Insulin Pens 12
4.3.2 Insulin Syringes 13
4.3.3 Insulin Pumps
13
4.3.4 Traditional Insulin Pump Accessories 13
5 Healthcare Sector
Review 14
5.1 Healthcare Expenditure 14
5.2 Healthcare Infrastructure
18
5.3 Healthcare Policy 22
5.4 Canada Healthcare Trade Statistics
23
6 Regulation System 24
6.1 Medical Equipment Approval Process
24
6.1.1 Classification 24
6.1.2 Conformity Assessment 25
6.1.3
License Fee 26
6.1.4 License Application Processing Duration 26
6.2
Labeling and Packaging 27
6.3 Post-Market Surveillance 27
7 Pricing
and Reimbursement 28
8 Distribution Structure 30
8.1 Distribution
Structure 30
9 Diabetes Care Devices In Canada 31
9.1 Diabetes Care
Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
9.2 Diabetes Care
Devices, Canada, Category Volume (Units), 2000-2015 34
9.3 Diabetes Care
Devices, Canada, Cross-Category Analysis, 2000-2015 36
9.4 Diabetes Care
Devices, Canada, Company Share (2007-2008) 37
10 Glucose Monitoring In
Canada 39
10.1 Glucose Monitoring Overall Revenue (2000-2015) 39
10.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 41
10.2 Glucose
Monitoring Overall Volume (2000-2015) 43
10.2.1 Blood Glucose Meters
Overall Volume (2000-2015) 44
10.3 Glucose Monitoring, Canada,
Cross-Segment Analysis, 2000-2015 46
10.4 Glucose Monitoring Average Price
(2000-2015) 47
10.5 Glucose Monitoring Market Dynamics 48
10.5.1
Market Drivers 48
10.5.2 Market Restraints 48
10.6 Glucose Monitoring
Distribution Share (2007-2008) 48
10.7 Glucose Monitoring, Canada, Company
Share (2007-2008) 49
11 Insulin Delivery In Canada 51
11.1 Insulin
Delivery Overall Revenue (2000-2015) 51
11.1.1 Insulin Pens Overall
Revenue (2000-2015) 54
11.2 Insulin Delivery Overall Volume (2000-2015)
56
11.2.1 Insulin Pens Overall Volume (2000-2015) 57
11.3 Insulin
Delivery, Canada, Cross-Segment Analysis, 2000-2015 59
11.4 Insulin
Delivery Average Price (2000-2015) 60
11.5 Insulin Delivery Market
Dynamics 61
11.6 Insulin Delivery Distribution Share (2007-2008) 62
11.7 Insulin Delivery, Canada, Company Share (2007-2008) 62
12 Overview of
Key Companies in Canada Diabetes Care Devices Market 64
12.1 F.
Hoffmann-La Roche Ltd. 64
12.1.1 Company Overview 64
12.1.2 Value
Chain Analysis 64
12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 66
12.2 Bayer HealthCare AG 67
12.2.1 Company Overview 67
12.2.2 Value
Chain Analysis 67
12.2.3 Bayer HealthCare AG Pipeline Products 69
12.3
LifeScan, Inc. 71
12.3.1 Company Overview 71
12.3.2 LifeScan, Inc.
Pipeline Products 71
12.4 Abbott Laboratories 73
12.4.1 Company
Overview 73
12.4.2 Value Chain Analysis 73
12.4.3 Abbott Laboratories
Pipeline Products 75
12.5 Novo Nordisk A/S 77
12.5.1 Company Overview
77
12.5.2 Novo Nordisk A/S Pipeline Products 77
12.6 Sanofi-Aventis
78
12.6.1 Company Overview 78
12.7 Medtronic, Inc. 79
12.7.1
Company Overview 79
12.7.2 Value Chain Analysis 80
12.7.3 Medtronic,
Inc. Pipeline Products 82
12.8 Terumo Corporation 88
12.8.1 Company
Overview 88
12.8.2 Value Chain Analysis 88
12.9 Apex Biotechnology
Corp. 90
12.9.1 Company Overview 90
12.10 Becton, Dickinson and
Company 91
12.10.1 Company Overview 91
12.10.2 Value Chain Analysis
91
12.11 Eli Lilly and Company 93
12.11.1 Company Overview 93
12.11.2 Value Chain Analysis 93
12.11.3 Eli Lilly and Company Pipeline
Products 96
12.12 Animas Corporation 97
12.12.1 Company Overview
97
12.13 Smiths Medical 97
12.13.1 Company Overview 97
12.13.2
Value Chain Analysis 98
12.14 Glucoplus Inc. 100
12.14.1 Company
Overview 100
13 Appendix 101
13.1 GlobalData Research Methodology
101
13.2 Coverage 102
13.3 Secondary Research 103
13.4 Primary
Research 103
13.5 Models 104
13.6 Forecasts 104
13.7 Expert Panel
Validation 105
13.8 Currency Conversion 106
13.9 Contact Us 107
13.10 Disclaimer 107
1.1 List of Tables
Table 1: Healthcare
Expenditure, Canada, 2000-2007 17
Table 2: Number of Physicians by
Province in Canada, 2001 and 2005 18
Table 3: Number of Physicians by
Province in Canada, 2001 and 2007 19
Table 4: Hospital Wards by Specialty
in Canada, 2003-2007 20
Table 5: Doctors by Specialty in Canada, 2003-2007
21
Table 6: Canada Healthcare Trade Statistics, 2001-2006 23
Table 7:
Medical Equipment Classification in Canada, 2007 24
Table 8: Medical
Equipment Licensing Fee in Canada, 2007 26
Table 9: Medical Equipment
License Processing Duration in Canada, 2007 26
Table 10: Private
Reimbursement Providers, Canada 29
Table 11: Diabetes Care Devices,
Canada, Overall Revenue ($ mn), Historic, 2000-2008 31
Table 12:
Diabetes Care Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015
33
Table 13: Diabetes Care Devices, Canada, Category Volume (Units),
Historic, 2000-2008 34
Table 14: Diabetes Care Devices, Canada,
Category Volume (Units), Forecast, 2008-2015 35
Table 15: Diabetes Care
Devices, Canada, Cross-Category Analysis, 2000-2015 36
Table 16:
Diabetes Care Devices, Canada, Company Share by Revenue ($ mn), 2007-2008
38
Table 17: Glucose Monitoring, Canada, Revenue ($ mn) by Segment,
Historic, 2000-2008 39
Table 18: Glucose Monitoring, Canada, Revenue
($ mn) by Segment, Forecast, 2008-2015 40
Table 19: Blood Glucose
Meters, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 41
Table 20: Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 42
Table 21: Glucose Monitoring, Canada, Volume
(Units) by Segment, Historic, 2000-2008 43
Table 22: Glucose
Monitoring, Canada, Volume (Units) by Segment, Forecast, 2008-2015 43
Table 23: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment,
Historic, 2000-2008 44
Table 24: Blood Glucose Meters, Canada, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 45
Table 25: Glucose
Monitoring, Canada, Cross-Segment Analysis, 2000-2015 46
Table 26:
Glucose Monitoring, Canada, Average Price ($), Historic, 2000-2008 47
Table 27: Glucose Monitoring, Canada, Average Price ($), Forecast,
2008-2015 47
Table 28: Glucose Monitoring, Canada, Distribution Share
by Revenue ($mn), 2007-2008 48
Table 29: Glucose Monitoring, Canada,
Company Share by Revenue ($ mn), 2007-2008 49
Table 30: Insulin
Delivery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 51
Table
31: Insulin Delivery, Canada, Revenue ($ mn) by Segment, Forecast,
2008-2015 53
Table 32: Insulin Pens, Canada, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 54
Table 33: Insulin Pens, Canada,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 55
Table 34:
Insulin Delivery, Canada, Volume (Units) by Segment, Historic, 2000-2008
56
Table 35: Insulin Delivery, Canada, Volume (Units) by Segment,
Forecast, 2008-2015 56
Table 36: Insulin Pens, Canada, Volume (Units)
by Sub-Segment, Historic, 2000-2008 57
Table 37: Insulin Pens,
Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 58
Table 38:
Insulin Delivery, Canada, Cross-Segment Analysis, 2000-2015 59
Table 39:
Insulin Delivery, Canada, Average Price ($), Historic, 2000-2008 60
Table 40: Insulin Delivery, Canada, Average Price ($), Forecast,
2008-2015 60
Table 41: Insulin Delivery, Canada, Distribution Share
by Revenue ($mn), 2007-2008 62
Table 42: Insulin Delivery, Canada,
Company Share by Revenue ($ mn), 2007-2008 63
Table 43: F.
Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 66
Table 44:
F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 66
Table
45: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 67
Table 46: Bayer HealthCare AG Pipeline Products by Equipment Type 69
Table 47: Bayer HealthCare AG Pipeline Products by Development Stage
70
Table 48: Bayer HealthCare AG Pipeline Products by Therapy Area
70
Table 49: Bayer HealthCare AG Pipeline Products by News Summary
70
Table 50: LifeScan, Inc. Pipeline Products by Equipment Type
71
Table 51: LifeScan, Inc. Pipeline Products by Development Stage
71
Table 52: LifeScan, Inc. Pipeline Products by Therapy Area 71
Table 53: LifeScan, Inc. Pipeline Products by Clinical Trials 72
Table 54: LifeScan, Inc. Pipeline Products by News Summary 72
Table
55: Abbott Laboratories Pipeline Products by Equipment Type 75
Table
56: Abbott Laboratories Pipeline Products by Development Stage 76
Table 57: Abbott Laboratories Pipeline Products by Therapy Area 76
Table 58: Abbott Laboratories Pipeline Products by Clinical Trials
76
Table 59: Abbott Laboratories Pipeline Products by News Summary
76
Table 60: Novo Nordisk A/S Pipeline Products by Equipment Type
77
Table 61: Novo Nordisk A/S Pipeline Products By Development Stage
77
Table 62: Novo Nordisk A/S Pipeline Products By Therapy Area
77
Table 63: Novo Nordisk A/S Pipeline Products By Clinical Trials
78
Table 64: Medtronic, Inc. Pipeline Products by Equipment Type
82
Table 65: Medtronic, Inc. Pipeline Products By Development Stage
84
Table 66: Medtronic, Inc. Pipeline Products By Therapy Area 85
Table 67: Medtronic, Inc. Pipeline Products By Clinical Trials 86
Table 68: Medtronic, Inc. Pipeline Products By News Summary 87
Table
69: Eli Lilly and Company Pipeline Products by Equipment Type 96
Table 70: Eli Lilly and Company Pipeline Products by Development Stage
96
Table 71: Eli Lilly and Company Pipeline Products by Therapy Area
96
Table 72: Eli Lilly and Company Pipeline Products by Clinical
Trials 96
Table 73: Eli Lilly and Company Pipeline Products by News
Summary 96
Table 74: USD to Local Currency, Average Exchange Rate 2008
106
1.2 List of Figures
Figure 1: Healthcare Financing in Canada,
2004 15
Figure 2: Healthcare Expenditure, Canada, 2000 - 2007 16
Figure 3: Diabetes Care Devices, Canada, Overall Revenue ($ mn),
Historic, 2000-2008 31
Figure 4: Diabetes Care Devices, Canada,
Overall Revenue ($ mn), Forecast, 2008-2015 32
Figure 5: Diabetes
Care Devices, Canada, Category Volume (Units), Historic, 2000-2008 34
Figure 6: Diabetes Care Devices, Canada, Category Volume (Units),
Forecast, 2008-2015 35
Figure 7: Diabetes Care Devices, Canada,
Cross-Category Analysis, 2000-2015 36
Figure 8: Diabetes Care
Devices, Canada, Company Share (%), 2008 37
Figure 9: Blood Glucose
Meters, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 41
Figure 10: Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 42
Figure 11: Blood Glucose Meters, Canada,
Volume (Units) by Sub-Segment, Historic, 2000-2008 44
Figure 12:
Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Forecast,
2008-2015 45
Figure 13: Glucose Monitoring, Canada, Cross-Segment
Analysis, 2000-2015 46
Figure 14: Glucose Monitoring, Canada, Company
Share (%), 2008 49
Figure 15: Insulin Delivery, Canada, Revenue ($
mn) by Segment, Historic, 2000-2008 51
Figure 16: Insulin Delivery,
Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 52
Figure 17:
Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
54
Figure 18: Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 55
Figure 19: Insulin Pens, Canada, Volume
(Units) by Sub-Segment, Historic, 2000-2008 57
Figure 20: Insulin
Pens, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 58
Figure
21: Insulin Delivery, Canada, Cross-Segment Analysis, 2000-2015 59
Figure 22: Insulin Delivery, Canada, Company Share (%), 2008 62
Figure 23: GlobalData Methodology 102
|
Related Report
|
View Cart
